Sarah Creytens 1 – 3 of 3 publications Show 10 5 10 15 20 50 100 250 Sort by year (new to old) Actions Filter publications Download search results Subscribe to news feed Add to list Journal Article A1 open access Influenza neuraminidase characteristics and potential as a vaccine target Sarah Creytens (UGent) , Mirte N. Pascha, Marlies Ballegeer (UGent) , Xavier Saelens (UGent) and Cornelis A. M. de Haan (2021) FRONTIERS IN IMMUNOLOGY. 12. Add to list Journal Article A1 open access An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models Bert Schepens (UGent) , Loes van Schie (UGent) , Wim Nerinckx (UGent) , Kenny Roose (UGent) , Wander Van Breedam (UGent) , Daria Fijalkowska (UGent) , Simon Devos (UGent) , Wannes Weyts (UGent) , Sieglinde De Cae (UGent) , Sandrine Vanmarcke (UGent) , et al. (2021) SCIENCE TRANSLATIONAL MEDICINE. 13(621). Add to list Journal Article A1 open access Selective engagement of FcγRIV by a M2e-specific single domain antibody construct protects against influenza A virus infection Dorien De Vlieger, Katja Hoffmann, Inge Van Molle, Wim Nerinckx (UGent) , Lien Van Hoecke (UGent) , Marlies Ballegeer (UGent) , Sarah Creytens (UGent) , Han Remaut, Hartmut Hengel, Bert Schepens (UGent) , et al. (2019) FRONTIERS IN IMMUNOLOGY. 10.
